Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 4
1993 3
1995 3
1996 3
1997 5
1998 6
1999 3
2000 7
2001 3
2002 2
2003 3
2004 5
2005 9
2006 2
2007 4
2008 5
2009 7
2010 10
2011 3
2012 3
2013 2
2014 4
2015 4
2016 3
2017 5
2018 3
2019 5
2020 6
2021 4
2022 1
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Results by year
Filters applied: . Clear all
Page 1
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism.
García-Silva S, Benito-Martín A, Nogués L, Hernández-Barranco A, Mazariegos MS, Santos V, Hergueta-Redondo M, Ximénez-Embún P, Kataru RP, Lopez AA, Merino C, Sánchez-Redondo S, Graña-Castro O, Matei I, Nicolás-Avila JÁ, Torres-Ruiz R, Rodríguez-Perales S, Martínez L, Pérez-Martínez M, Mata G, Szumera-Ciećkiewicz A, Kalinowska I, Saltari A, Martínez-Gómez JM, Hogan SA, Saragovi HU, Ortega S, Garcia-Martin C, Boskovic J, Levesque MP, Rutkowski P, Hidalgo A, Muñoz J, Megías D, Mehrara BJ, Lyden D, Peinado H. García-Silva S, et al. Among authors: saragovi hu. Nat Cancer. 2021 Dec;2(12):1387-1405. doi: 10.1038/s43018-021-00272-y. Epub 2021 Nov 25. Nat Cancer. 2021. PMID: 34957415 Free PMC article.
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Huang F, Gonçalves C, Bartish M, Rémy-Sarrazin J, Issa ME, Cordeiro B, Guo Q, Emond A, Attias M, Yang W, Plourde D, Su J, Gimeno MG, Zhan Y, Galán A, Rzymski T, Mazan M, Masiejczyk M, Faber J, Khoury E, Benoit A, Gagnon N, Dankort D, Journe F, Ghanem GE, Krawczyk CM, Saragovi HU, Piccirillo CA, Sonenberg N, Topisirovic I, Rudd CE, Miller WH Jr, Del Rincón SV. Huang F, et al. Among authors: saragovi hu. J Clin Invest. 2021 Apr 15;131(8):e140752. doi: 10.1172/JCI140752. J Clin Invest. 2021. PMID: 33690225 Free PMC article.
Novel approaches for targeted cancer therapy.
Guillemard V, Saragovi HU. Guillemard V, et al. Among authors: saragovi hu. Curr Cancer Drug Targets. 2004 Jun;4(4):313-26. doi: 10.2174/1568009043332989. Curr Cancer Drug Targets. 2004. PMID: 15180497 Review.
Effective chimeric antigen receptor T cells against SARS-CoV-2.
Guo X, Kazanova A, Thurmond S, Saragovi HU, Rudd CE. Guo X, et al. Among authors: saragovi hu. iScience. 2021 Nov 19;24(11):103295. doi: 10.1016/j.isci.2021.103295. Epub 2021 Oct 16. iScience. 2021. PMID: 34693218 Free PMC article.
Reovirus receptors.
Sauvé GJ, Saragovi HU, Greene MI. Sauvé GJ, et al. Among authors: saragovi hu. Adv Virus Res. 1993;42:325-41. doi: 10.1016/s0065-3527(08)60088-3. Adv Virus Res. 1993. PMID: 8430522 Review. No abstract available.
123 results